A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer

Dennis S. Chi, Rebecca Phäeton, Thomas J. Miner, Steven V. Kardos, John P. Diaz, Mario M. Leitao, Ginger Gardner, Jae Huh, William P. Tew, Jason A. Konner, Yukio Sonoda, Nadeem R. Abu-Rustum, Richard R. Barakat, David P. Jaques

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Objective. To obtain prospective outcomes data on patients (pts) undergoing palliative operative or endoscopic procedures for malignant bowel obstruction due to recurrent ovarian cancer. Methods. An institutional study was conducted from July 2002 to July 2003 to prospectively identify pts who underwent an operative or endoscopic procedure to palliate the symptoms of advanced cancer. This report focuses on pts with malignant bowel obstruction due to recurrent ovarian cancer. Procedures performed with an upper or lower gastrointestinal (GI) endoscope were considered "endoscopic." All other cases were classified as "operative." Following the procedure, the presence or absence of symptoms was determined and followed over time. All pts were followed until death. Results. Palliative interventions were performed on 74 gynecologic oncology pts during the study period, of which 26 (35%) were for malignant GI obstruction due to recurrent ovarian cancer. The site of obstruction was small bowel in 14 (54%) cases and large bowel in 12 (46%) cases. Palliative procedures were operative in 14 (54%) pts and endoscopic in the other 12 (46%). Overall, symptomatic improvement or resolution within 30 days was achieved in 23 (88%) of 26 patients, with 1 (4%) postprocedure mortality. At 60 days, 10 (71%) of 14 pts who underwent operative procedures and 6 (50%) of 12 pts who had endoscopic procedures had symptom control. Median survival from the time of the palliative procedure was 191 days (range, 33-902) for those undergoing an operative procedure and 78 days (range, 18 -284) for those undergoing an endoscopic procedure. Conclusion. Patients with malignant bowel obstructions due to recurrent ovarian cancer have a high likelihood of experiencing relief of symptoms with palliative procedures. Although recurrence of symptoms is common, durable palliation and extended survival are possible, especially in those patients selected for operative intervention.

Original languageEnglish
Pages (from-to)835-839
Number of pages5
JournalOncologist
Volume14
Issue number8
DOIs
StatePublished - Aug 1 2009

Fingerprint

Intestinal Obstruction
Ovarian Neoplasms
Operative Surgical Procedures
Gastrointestinal Endoscopes
Survival
Recurrence

Keywords

  • End-of-life care
  • Palliative surgery
  • Recurrent gynecologic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chi, D. S., Phäeton, R., Miner, T. J., Kardos, S. V., Diaz, J. P., Leitao, M. M., ... Jaques, D. P. (2009). A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist, 14(8), 835-839. https://doi.org/10.1634/theoncologist.2009-0057

A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. / Chi, Dennis S.; Phäeton, Rebecca; Miner, Thomas J.; Kardos, Steven V.; Diaz, John P.; Leitao, Mario M.; Gardner, Ginger; Huh, Jae; Tew, William P.; Konner, Jason A.; Sonoda, Yukio; Abu-Rustum, Nadeem R.; Barakat, Richard R.; Jaques, David P.

In: Oncologist, Vol. 14, No. 8, 01.08.2009, p. 835-839.

Research output: Contribution to journalArticle

Chi, DS, Phäeton, R, Miner, TJ, Kardos, SV, Diaz, JP, Leitao, MM, Gardner, G, Huh, J, Tew, WP, Konner, JA, Sonoda, Y, Abu-Rustum, NR, Barakat, RR & Jaques, DP 2009, 'A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer', Oncologist, vol. 14, no. 8, pp. 835-839. https://doi.org/10.1634/theoncologist.2009-0057
Chi, Dennis S. ; Phäeton, Rebecca ; Miner, Thomas J. ; Kardos, Steven V. ; Diaz, John P. ; Leitao, Mario M. ; Gardner, Ginger ; Huh, Jae ; Tew, William P. ; Konner, Jason A. ; Sonoda, Yukio ; Abu-Rustum, Nadeem R. ; Barakat, Richard R. ; Jaques, David P. / A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. In: Oncologist. 2009 ; Vol. 14, No. 8. pp. 835-839.
@article{fcc83ec5760e46839c1f53ff2186e863,
title = "A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer",
abstract = "Objective. To obtain prospective outcomes data on patients (pts) undergoing palliative operative or endoscopic procedures for malignant bowel obstruction due to recurrent ovarian cancer. Methods. An institutional study was conducted from July 2002 to July 2003 to prospectively identify pts who underwent an operative or endoscopic procedure to palliate the symptoms of advanced cancer. This report focuses on pts with malignant bowel obstruction due to recurrent ovarian cancer. Procedures performed with an upper or lower gastrointestinal (GI) endoscope were considered {"}endoscopic.{"} All other cases were classified as {"}operative.{"} Following the procedure, the presence or absence of symptoms was determined and followed over time. All pts were followed until death. Results. Palliative interventions were performed on 74 gynecologic oncology pts during the study period, of which 26 (35{\%}) were for malignant GI obstruction due to recurrent ovarian cancer. The site of obstruction was small bowel in 14 (54{\%}) cases and large bowel in 12 (46{\%}) cases. Palliative procedures were operative in 14 (54{\%}) pts and endoscopic in the other 12 (46{\%}). Overall, symptomatic improvement or resolution within 30 days was achieved in 23 (88{\%}) of 26 patients, with 1 (4{\%}) postprocedure mortality. At 60 days, 10 (71{\%}) of 14 pts who underwent operative procedures and 6 (50{\%}) of 12 pts who had endoscopic procedures had symptom control. Median survival from the time of the palliative procedure was 191 days (range, 33-902) for those undergoing an operative procedure and 78 days (range, 18 -284) for those undergoing an endoscopic procedure. Conclusion. Patients with malignant bowel obstructions due to recurrent ovarian cancer have a high likelihood of experiencing relief of symptoms with palliative procedures. Although recurrence of symptoms is common, durable palliation and extended survival are possible, especially in those patients selected for operative intervention.",
keywords = "End-of-life care, Palliative surgery, Recurrent gynecologic cancer",
author = "Chi, {Dennis S.} and Rebecca Ph{\"a}eton and Miner, {Thomas J.} and Kardos, {Steven V.} and Diaz, {John P.} and Leitao, {Mario M.} and Ginger Gardner and Jae Huh and Tew, {William P.} and Konner, {Jason A.} and Yukio Sonoda and Abu-Rustum, {Nadeem R.} and Barakat, {Richard R.} and Jaques, {David P.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1634/theoncologist.2009-0057",
language = "English",
volume = "14",
pages = "835--839",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "8",

}

TY - JOUR

T1 - A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer

AU - Chi, Dennis S.

AU - Phäeton, Rebecca

AU - Miner, Thomas J.

AU - Kardos, Steven V.

AU - Diaz, John P.

AU - Leitao, Mario M.

AU - Gardner, Ginger

AU - Huh, Jae

AU - Tew, William P.

AU - Konner, Jason A.

AU - Sonoda, Yukio

AU - Abu-Rustum, Nadeem R.

AU - Barakat, Richard R.

AU - Jaques, David P.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Objective. To obtain prospective outcomes data on patients (pts) undergoing palliative operative or endoscopic procedures for malignant bowel obstruction due to recurrent ovarian cancer. Methods. An institutional study was conducted from July 2002 to July 2003 to prospectively identify pts who underwent an operative or endoscopic procedure to palliate the symptoms of advanced cancer. This report focuses on pts with malignant bowel obstruction due to recurrent ovarian cancer. Procedures performed with an upper or lower gastrointestinal (GI) endoscope were considered "endoscopic." All other cases were classified as "operative." Following the procedure, the presence or absence of symptoms was determined and followed over time. All pts were followed until death. Results. Palliative interventions were performed on 74 gynecologic oncology pts during the study period, of which 26 (35%) were for malignant GI obstruction due to recurrent ovarian cancer. The site of obstruction was small bowel in 14 (54%) cases and large bowel in 12 (46%) cases. Palliative procedures were operative in 14 (54%) pts and endoscopic in the other 12 (46%). Overall, symptomatic improvement or resolution within 30 days was achieved in 23 (88%) of 26 patients, with 1 (4%) postprocedure mortality. At 60 days, 10 (71%) of 14 pts who underwent operative procedures and 6 (50%) of 12 pts who had endoscopic procedures had symptom control. Median survival from the time of the palliative procedure was 191 days (range, 33-902) for those undergoing an operative procedure and 78 days (range, 18 -284) for those undergoing an endoscopic procedure. Conclusion. Patients with malignant bowel obstructions due to recurrent ovarian cancer have a high likelihood of experiencing relief of symptoms with palliative procedures. Although recurrence of symptoms is common, durable palliation and extended survival are possible, especially in those patients selected for operative intervention.

AB - Objective. To obtain prospective outcomes data on patients (pts) undergoing palliative operative or endoscopic procedures for malignant bowel obstruction due to recurrent ovarian cancer. Methods. An institutional study was conducted from July 2002 to July 2003 to prospectively identify pts who underwent an operative or endoscopic procedure to palliate the symptoms of advanced cancer. This report focuses on pts with malignant bowel obstruction due to recurrent ovarian cancer. Procedures performed with an upper or lower gastrointestinal (GI) endoscope were considered "endoscopic." All other cases were classified as "operative." Following the procedure, the presence or absence of symptoms was determined and followed over time. All pts were followed until death. Results. Palliative interventions were performed on 74 gynecologic oncology pts during the study period, of which 26 (35%) were for malignant GI obstruction due to recurrent ovarian cancer. The site of obstruction was small bowel in 14 (54%) cases and large bowel in 12 (46%) cases. Palliative procedures were operative in 14 (54%) pts and endoscopic in the other 12 (46%). Overall, symptomatic improvement or resolution within 30 days was achieved in 23 (88%) of 26 patients, with 1 (4%) postprocedure mortality. At 60 days, 10 (71%) of 14 pts who underwent operative procedures and 6 (50%) of 12 pts who had endoscopic procedures had symptom control. Median survival from the time of the palliative procedure was 191 days (range, 33-902) for those undergoing an operative procedure and 78 days (range, 18 -284) for those undergoing an endoscopic procedure. Conclusion. Patients with malignant bowel obstructions due to recurrent ovarian cancer have a high likelihood of experiencing relief of symptoms with palliative procedures. Although recurrence of symptoms is common, durable palliation and extended survival are possible, especially in those patients selected for operative intervention.

KW - End-of-life care

KW - Palliative surgery

KW - Recurrent gynecologic cancer

UR - http://www.scopus.com/inward/record.url?scp=70249092230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249092230&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2009-0057

DO - 10.1634/theoncologist.2009-0057

M3 - Article

C2 - 19684071

AN - SCOPUS:70249092230

VL - 14

SP - 835

EP - 839

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 8

ER -